Coronavirus News & Updates

By Michael Erman and Manas Mishra (Reuters) - U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine for at least a few...

By Julie Steenhuysen and Kate Kelland CHICAGO/LONDON (Reuters) - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood clots in the brain,...

By Sudipto Ganguly (Reuters) - World number two Daniil Medvedev of Russia has tested positive for COVID-19 and has been withdrawn from this week's Monte Carlo Masters, the ATP...

By Carl O'Donnell (Reuters) - Novavax (NASDAQ:NVAX) Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the...

(Reuters) - The United States reported an 8% rise in new cases of COVID-19 to 490,000 last week, the fourth week in a row that infections have increased, according to a Reuters...

GENEVA (Reuters) -Confusion and complacency in addressing COVID-19 means the pandemic is a long way from over, but it can be brought under control in months with proven public...

By John Miller ZURICH (Reuters) -Regeneron is pursuing U.S. approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of...

By Neha Arora and Rajendra Jadhav NEW DELHI, (Reuters) -Hundreds of thousands of Hindu devotees flocked on Monday to take a holy bath in India's Ganges river, even as the nation...

BEIJING (Reuters) -China's top disease control official has said the country is formally considering mixing COVID-19 vaccines as a way of further boosting vaccine efficacy....

MELBOURNE (Reuters) - Athletics Australia said they will not send athletes to next month's World Athletics Relay Championships in Poland due to the COVID-19 situation, a decision...

(Reuters) - The United States had administered 187,047,131 doses of COVID-19 vaccines and distributed 237,796,105 doses as of Sunday, the U.S. Centers for Disease Control and...

By Paulina Duran SYDNEY (Reuters) - Australia has abandoned a goal to vaccinate nearly all of its 26 million population by the end of 2021 following advice that people under the...

By Devjyot Ghoshal and Krishna N. Das NEW DELHI (Reuters) -India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand...

TOKYO (Reuters) - Tokyo Olympic organisers plan to prepare 300 hotel rooms for athletes who test positive for the coronavirus at this summer's Games but show no or minor symptoms...

(Reuters) - The United States had administered 183,467,709 doses of COVID-19 vaccines and distributed 237,791,735 doses as of Saturday morning, the U.S. Centers for Disease...

By Aislinn Laing SANTIAGO (Reuters) - The archbishop of Chile's capital Santiago, Celestino Aos, has been hospitalized after testing positive for the coronavirus, the Roman...

By Nancy Lapid (Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19,...

By Amy Tennery (Reuters) - Amid the monotony of quarantine life that people had to put up with due to the outbreak of COVID-19, housebound residents in one corner of Los Angeles...

(Reuters) - Frenchman Richard Gasquet said on Friday that he was pulling out of next week's Monte Carlo Masters because of "complications related to COVID-19". The world number...

(Reuters) - Pfizer Inc (NYSE:PFE) and its German partner BioNTech SE (NASDAQ:BNTX) said on Friday they have requested the U.S. Food and Drug Administration to expand the...

By Carl O'Donnell (Reuters) - Johnson & Johnson (NYSE:JNJ) will ship relatively few COVID-19 shots around the United States until it receives regulatory clearance for a large...

By Sudip Kar-Gupta and Benoit Van Overstraeten PARIS (Reuters) - France's top health advisory body in charge of COVID-19 vaccines recommended on Friday that recipients of a first...

By Nancy Lapid (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19,...

SHANGHAI (Reuters) -A joint China-World Health Organization (WHO) study into COVID-19 has provided no credible answers about how the pandemic began, and more rigorous...

By Jeffrey Heller JERUSALEM (Reuters) - A memorial siren brought traffic to a halt in Israel on Thursday as it honoured six million Jews killed in the Nazi Holocaust, and gave...

PARIS (Reuters) - This year's French Open has been postponed by a week due to the COVID-19 pandemic and will begin on May 30, the French Tennis Federation (FFT) said on Thursday....

Singapore (Reuters) - India, South Korea and Thailand faced mounting coronavirus infections on Thursday, undermining cautious hopes that Asia might be emerging from the worst of...

By Krishna N. Das and Sachin Ravikumar NEW DELHI (Reuters) - India's COVID-19 cases have soared 13-fold in barely two months, a vicious second wave propelled by open disregard for...

By Eliana Raszewski BUENOS AIRES (Reuters) - Argentina tightened movement restrictions on Wednesday including curtailing the leisure industry and blocking nonessential workers...

By Cassandra Garrison MEXICO CITY (Reuters) - Mexico's private healthcare personnel are protesting being left out of the government's COVID-19 vaccine rollout, just as the country...

(Reuters) - The number of people testing positive for COVID-19 at the Vancouver Canucks has gone up to 25, which includes 21 players and four members of staff, the NHL team said...

By Julia Symmes Cobb BOGOTA (Reuters) - South America is the most worrying region for COVID-19 infections, as cases mount in nearly every country, the director of the Pan American...

By Pedro Fonseca RIO DE JANEIRO (Reuters) - Brazil has recorded its first confirmed case of the highly contagious coronavirus variant discovered in South Africa, a fresh danger...

WASHINGTON (Reuters) - The United States has delivered about 3 million COVID-19 vaccine doses per day on average over the past week, up 8% over the previous 7-day average, U.S....

(Reuters) -The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by...